06/21/2012 - 11:49am

The Food and Drug Administration has approved a branded acne drug made by Ranbaxy Labs, the drug maker said. Ranbaxy announced the FDA approval of Absorica (isotretinoin), a drug for treating severe recalcitrant nodular acne.

06/21/2012 - 11:47am

While the picture of a new Rx-to-OTC switch paradigm is being painted with a broad stroke brush, already there are two divergent pathways emerging around what that new paradigm landscape might look like. 


06/21/2012 - 9:15am

The Food and Drug Administration has approved a new indication for a Pfizer drug.

06/20/2012 - 11:01am

Pharmacy customers who use the Mscripts application to order, refill and manage their prescriptions now can do so in English or Spanish, the company announced Wednesday.

06/20/2012 - 10:56am

Hamacher Resource Group on Tuesday announced it will present “Marketing Diabetes in the Retail Setting” June 21 at the Marketing Diabetes Prevention and Awareness Conference in Atlanta.

06/19/2012 - 2:07pm

A Takeda drug designed to treat hypertension was statistically superior to a competing drug in reducing systolic blood pressure among patients in a late-stage clinical trial.

06/19/2012 - 11:18am

Maxim Health Systems now is a certified distributor of the Citi Flu Care card, the healthcare group announced Tuesday.

06/19/2012 - 10:15am

A drug maker and a teaching and research affiliate of Harvard Medical School announced a new collaboration to promote the development of new medicines for the treatment of diabetes and related disorders.

06/19/2012 - 10:00am

Pfizer announced the results of its late-stage clinical trial of Xalkori (crizotinib).